Medication adherence and attrition to biologic treatment in rheumatoid arthritis patients.

@article{Chu2015MedicationAA,
  title={Medication adherence and attrition to biologic treatment in rheumatoid arthritis patients.},
  author={Leungwing Chu and Aniket A. Kawatkar and Sherine E. Gabriel},
  journal={Clinical therapeutics},
  year={2015},
  volume={37 3},
  pages={660-666.e8}
}
PURPOSE The objectives of this study were to assess medication adherence rate and attrition rate in first-time adalimumab (ADA) or etanercept (ETA) users in rheumatoid arthritis (RA) patients. This study also identified the risk factors associated with nonadherence and treatment abandonment. METHODS This was a retrospective study with a 2-year follow-up. A total 2151 adult RA patients (18 years of age and older) who initiated ADA or ETA treatment in the Kaiser Permanente Southern California… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…